Springer Seminars in Immunopathology

, Volume 4, Issue 1, pp 55–63

Biology of the mast cell and its role in cutaneous inflammation

  • Bruce U. Wintroub
  • Nicholas A. Soter
Article

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Atkins P C, Norman M E, Zweimann B (1978) Antigen induced neutrophil chemotactic activity in man. Correlation with bronchospasm and inhibition by disodium cromolgycate. J Allergy Clin Immunol 62: 149PubMedGoogle Scholar
  2. 2.
    Bach M K, Brashler JR, Gorman RR (1977) On the structure of slow reacting substance of anaphylaxis: evidence of biosynthesis from arachidonic acid. Prostaglandins 14: 21PubMedGoogle Scholar
  3. 3.
    Black J W, Duncan WAM, Durant CJ, Ganellin CR, Parsons EM (1972) Definition and antagonism of histamine H2-receptors. Nature 236: 385PubMedGoogle Scholar
  4. 4.
    Bloom G D (1974) Structural and biochemical characteristics of mast cells. In: Zweifach BW, Grant L, McCluskey RT (eds) The inflammatory process. Academic Press, New York, P 545Google Scholar
  5. 5.
    Boswell R N, Austen KF, Goetzl EJ (1978). Intermediate molecular weight eosinophil chemotactic factors in rat peritoneal mast cells: immunological release, granule association, and demonstration of structural heterogeneity. J Immunol 120: 15PubMedGoogle Scholar
  6. 6.
    Brocklehurst W E (1960) The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphyactic shock. J Physiol 151: 416PubMedGoogle Scholar
  7. 7.
    Caulfield JP, Lewis RA, Hein A, Austen KF (1980) Secretion in dissociated human pulmonary mast cells. J Cell Biol 85: 299PubMedGoogle Scholar
  8. 8.
    Clark R A F, Gallin JI, Kaplan AP (1975) The selective eosinophil chemotactic activity of histamine. J Exp Med 142: 1462PubMedGoogle Scholar
  9. 9.
    Clark R A F, Sandler JA, Gallin JI, Kaplan AP (1977) Histamine modulation of eosinophil migration. J Immunol 118: 137PubMedGoogle Scholar
  10. 10.
    Conrad D H, Bazin H, Sehon AH, Froese A (1975) Binding parameters of the interaction between rat IgE and rat mast cell receptors. J Immunol 114: 1688PubMedGoogle Scholar
  11. 11.
    Demopoulos C A, Pinckard RN, Hanahan DJ (1979) Platelet activating factor: evedence for 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 254: 9355PubMedGoogle Scholar
  12. 12.
    Dousa T P, Code CF (1974) Effect of histamine and its methyl derivatives on cyclic AMP metabolism in gastric mucosa and its blockage by an H2 receptor antagonist. J Clin Invest 53: 334PubMedGoogle Scholar
  13. 13.
    Drazen J M, Lewis RA, Wasserman SI, Orange RP, Austen KF (1979) Differential effects of a partially purified preparation of slow-reacting substance of anaphylaxis on guinea pig tracheal spirals and parenchymal strips. J Clin Invest 63: 1PubMedGoogle Scholar
  14. 14.
    Fedorko M F, Hirsch JG (1965) Crystalloid structures in granules of guinea pig basophils and human mast cells. J Cell Biol 26: 973Google Scholar
  15. 15.
    Goetzl E J, Austen KF (1975) Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sci USA 72: 4123PubMedGoogle Scholar
  16. 16.
    Goetzl E J, Gorman RR (1978) Chemotactic and chemokinetic stimulation of human eosinophil and neutrophil polymorphonuclear leukocytes by 12-L-hydroxy-5, 8, 10-heptadecatrioenic acid (HHT). J Immunol 120: 526PubMedGoogle Scholar
  17. 17.
    Goetzl E J, Woods JM, Gorman RR (1977) Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and rnadom migration by 12-L-hydroxy-5, 8, 10, 14-eicosatetraenoic acid. J Clin Invest 59: 179PubMedGoogle Scholar
  18. 18.
    Gomori G (1953) Chloroacetyl esters as histochemical substrates. J Histochem Cytochem 1: 469PubMedGoogle Scholar
  19. 19.
    Greaves M, Marks R, Robertson I (1977) Receptors for histamine in human skin blood vessels: a review. Br J Dermatol 97: 225PubMedGoogle Scholar
  20. 20.
    Henson P M (1977) Activation of rabbit platelets by platelet-activating factor derived from IgEsensitized basophils: characteristics of the aggregation and its dissociation from secretion. J Clin Invest 60: 481PubMedGoogle Scholar
  21. 21.
    Holgate S, Lewis RA, Austen KF (to be published). Cyclic AMP and the release reaction. Prog ImmunolGoogle Scholar
  22. 22.
    Jakschik B A, Falkenhein S, Parker CW (1977) Precursor role of arachidonic acid in releas of slow reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sci USA 74: 4577PubMedGoogle Scholar
  23. 23.
    Johnson A R, Hugli RE, Möller-Eberhard HJ (1975) Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology 28: 1067PubMedGoogle Scholar
  24. 24.
    Kaliner M, Orange RP, Austen KF (1972) Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. IV. Enhancement by cholinergic and alpha-adrenergic stimulation. J Exp Med 136: 556PubMedGoogle Scholar
  25. 25.
    Kay AB, Austen KF (1971) The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J Immuol 107: 899Google Scholar
  26. 26.
    Kay AB, Stechschulte DJ, Austen KF (1971) An eosinophil leukocyte chemotactic factor of anaphylaxis. J Exp Med 133: 602PubMedGoogle Scholar
  27. 27.
    Kiernan JA (1975) A pharmacological and histological investigation of the involvement of mast cells in cutaneous axon reflex vasodilatation. Q J Exp Physiol 60: 123Google Scholar
  28. 28.
    König W, Ishizaka K (1974) Specific binding of mouse IgE with rat mast cells. J Immunol 112:1642Google Scholar
  29. 29.
    Kravis TC, Henson PM (1977) Accumulation of platelets at sites of antigen-antibody-mediated injury: a possible role for IgE antibody and mast cells. J Immunol 118: 1569PubMedGoogle Scholar
  30. 30.
    Lagunoff D (1972) Contributions of electron microscopy to the study of mast cells. J Invest Dermatol 58: 296PubMedGoogle Scholar
  31. 31.
    Lagunoff D, Pritzl P, Mueller L (1970)N-Acetyl-β-glucosaminidase in rat mast cell granules. Exp Cell Res 61: 129PubMedGoogle Scholar
  32. 32.
    Lewis RA, Austen KF, Drazen JM, Clark DA, Corey EJ to be published Slow reacting substance of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. Proc Natl Acad Sci USAGoogle Scholar
  33. 33.
    Loos M, Volanakis JE, Stroud RM (1976) Mode of interaction of different polyanions with the first (C1, CT), the second (C2) and the fourth (C4) component of complement-II. Effect of polyanions on the binding of C2 to EAC4b. Immunochemistry 13: 257PubMedGoogle Scholar
  34. 34.
    Lynch SM, Austen KF, Wasserman SI (1978) Release of arylsulfatase A but not B from rat mast cells by noncytolytic secretory stimuli. J Immunol 121: 1394PubMedGoogle Scholar
  35. 35.
    McNeill JH, Verma SC (1974) Blockade by burimamide of the effects of histamine and histamine analogs on cardiac contractility, phosphorylase activation and cyclic adenosine monophosphate. J Pharmacol Exp Ther 188: 180PubMedGoogle Scholar
  36. 36.
    Majno G, Palade GE, Schoefl GI (1961) Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J Biophys Biochem Cytol 11: 607PubMedGoogle Scholar
  37. 37.
    Metcalfe DD, Lewis RA, Silbert JE, Rosenberg RD, Wasserman SI, Austen KF (1978) Isolation, identification, and characterization of heparin from human lung. Fed Proc 37: 1776Google Scholar
  38. 38.
    Metcalfe DD, Soter NA, Wasserman SI, Austen KF (1980) Identification of sulfated mucopolysaccharides, including heparin, in the lesional skin of a patient with mastocytosis. J Invest Dermatol 74: 210PubMedGoogle Scholar
  39. 39.
    Mikhail GR, Miller-Milinska A (1964) Mast cell population in human skin. J Invest Dermatol 43: 249PubMedGoogle Scholar
  40. 40.
    Moriyasu S, Yamura T (1973) Electron microscopic studies of mast cell degranulation. Acta Derm Venereol (Stockh.) 53 (Suppl 73): 149Google Scholar
  41. 41.
    Morrison DG, Henson PM (1978) Release of mediators from mast cells and basophils induced by different stimuli. In: Bach MK (ed) Immediate hypersensitivity. Modern concepts and developments. Marcel Dekker, New York and Basel, p 431Google Scholar
  42. 42.
    Murphy RC, Hammarström S, Samuelson B (1979) Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc Natl Acad Sci USA 76: 4275PubMedGoogle Scholar
  43. 43.
    Nadel JA (1973) Neurophysiologic aspects of asthma. In: Austen KF, Lichtenstein LM (eds) Asthma: Physiology, immunopharmacology and treatment. Academic Press, New York, P 29Google Scholar
  44. 44.
    Orange RP, Austen KF (1969) Slow reacting substance of anaphylaxis. Adv Immunol 10: 105PubMedGoogle Scholar
  45. 45.
    Padawer J (1978) The mast cell and immediate hypersensitivity. In: Bach MK (ed) Immediate hypersensitivity. Modern concepts and developments. Marcel Dekker, New York and Basel, p 431Google Scholar
  46. 46.
    Paterson NAM, Wasserman SI, Said JW, Austen KF (1976) Release of chemical mediators from partially purified human hing mast cells. J Immunol 117: 1356PubMedGoogle Scholar
  47. 47.
    Pugh D, Walker PG (1961) Histochemical localization of β-glucuronidase andN-acetyl-β-glucosaminidase. J Histochem Cytochem 9: 105PubMedGoogle Scholar
  48. 48.
    Rocha e Silva M, Bier O, Aronson M (1951) Histamine release by anaphylatoxin. Nature 168: 465Google Scholar
  49. 49.
    Schayer RW (1965) Histamine and circulatory homeostasis. Fed Proc 24: 1295PubMedGoogle Scholar
  50. 50.
    Schwartz LB, Austen KF (1980) Enzymes of the mast cell granule. J Invest Dermatol 74: 349PubMedGoogle Scholar
  51. 51.
    Seppä HEJ (1978) Rat skin main neutral protease: immunohistochemical localization. J Invest Dermatol 71: 311PubMedGoogle Scholar
  52. 52.
    Soter N A (1980) High molecular weight neutrophil chemotactic factor: recognition, characterization, and role in the deactivation of neutrophilic leukocytes. J Invest Dermatol 74: 354PubMedGoogle Scholar
  53. 53.
    Soter N A, Mihm MC JR, Dvorak HF, Austen KF (1978) Cutaneous necrotizing venulitis: a sequential analysis of the morphologic alterations occurring after mast cell degranulation in a patient with a unique syndrome. Clin Exp Immunol 32: 46PubMedGoogle Scholar
  54. 54.
    Soter N A, Wasserman SI, Austen KF (1976) Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge. N Eugl J Med 294: 687Google Scholar
  55. 55.
    Soter N A, Wasserman SI, Austen KF, McFadden ER JR (1980) Mast cell mediator release and alteration in lung function in individuals with cholinergic urticaria. N Engl J Med 302: 604PubMedGoogle Scholar
  56. 56.
    Soter N A, Wasserman SI, Pathak MA, Parrish JA, Austen KF (1979) Solar urticaria: release of mast cell mediators into the circulation after experimental challenge. J Invest Dermatol 72: 282Google Scholar
  57. 57.
    Tomita A, Patterson R, Suszko IM (1974) Respiratory mast cells and basophiloid cells. Int Arch Allergy Appl Immunol 47: 261PubMedGoogle Scholar
  58. 58.
    Trotter C M, Orr TSC (1974) A fine structure study of some cellular components in allergic reactions. II. Mast cells in normal and atopic human skin. Clin Allergy 4: 421Google Scholar
  59. 59.
    Turnbull L W, Evans DP, Kay AB (1977) Human eosinophils, acidic tetrapeptides (ECF-A) and histamine: interactions in vitro and in vivo. Immunology 32: 57PubMedGoogle Scholar
  60. 60.
    Valone F H, Goetzl EJ (1978) Immunologic release in the peritoneal cavity of lipid chemotactic and chemokinetic factors for polymorphonuclear leukocytes. J Immunol 120: 102PubMedGoogle Scholar
  61. 61.
    Wasserman S I, Austen KF (1976) Arylsulfatase B of human lung: isolation, characterization, and interaction with slow-reacting substance of anaphylaxis. J Clin Invest 57: 738PubMedGoogle Scholar
  62. 62.
    Wasserman S I, Austen KF (1977) Identification and characterization of arylsulfatase A and B of the rat basophil leukemia tumor. J Biol Chem 252: 7074PubMedGoogle Scholar
  63. 63.
    Wasserman S I, Goetzl EJ, Austen KF (1975) Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. J Immunol 114: 645PubMedGoogle Scholar
  64. 64.
    Wasserman S I, Soter NA, Center DM, Austen KF (1977) Cold urticaria: recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest 60: 189PubMedGoogle Scholar
  65. 65.
    Wasserman S I, Soter NA, Poser J, Austen KF (1980) Eosinophil chemotactic factors in human disease; evidence of heterogeneity. Clin Res 28: 254AGoogle Scholar
  66. 66.
    Weiler J M, Yurt RW, Fearon DT, Austen KF (1978) Modulation of the formation of the amplification convertase of complement, C3b, Bb by native and commercial heparin. J Exp Med 147: 409PubMedGoogle Scholar
  67. 67.
    Woodbury R G, Gruzenski GM, Lagunoff D (1978) Immunofluorescent localization of a serine protease in rat small intestine. Proc Natl Acad Sci USA 75: 2785PubMedGoogle Scholar
  68. 68.
    Yurt R, Austen KF (1977) Preparative purification of the rat mast cell chymase: characterization and interaction with granule components. J Exp Med 146: 1405PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1981

Authors and Affiliations

  • Bruce U. Wintroub
    • 1
    • 2
  • Nicholas A. Soter
    • 1
    • 2
  1. 1.Department of DermatologyHarvard Medical SchoolBostonUSA
  2. 2.Immunodermatology Section of the Department of Rheumatology and Immunology and Division of DermatologyBrigham and Women's HospitalBostonUSA

Personalised recommendations